India's Divi's Laboratories March quarter net up 22 pct

MUMBAI, May 12 (Reuters) -
Three months ended March 31 versus the same period a year earlier
(In billion rupees unless stated)
Net Profit 2.2 vs 1.8
Net Sales 7.2 vs 4.8

Results are consolidated

NOTE: Divi's Laboratories Ltd is a drugmaker.

(Reporting by Shamik Paul; Editing by Toby Chopra)

symptoms for thrombosis